Login / Signup
Response to: 'Should patients starting biologics be screened for COVID-19?' by Cardenas-de la Garza et al.
Robert B M Landewe
Hendrik Schulze-Koops
Published in:
Annals of the rheumatic diseases (2020)
Keyphrases
</>
end stage renal disease
coronavirus disease
ejection fraction
sars cov
chronic kidney disease
prognostic factors
peritoneal dialysis